Alopecia areata after hepatitis C virus infection treatment: a case report

Authors : Esma EROĞLU

Pages : 185-187

Doi:10.38053/acmj.886644

View : 14 | Download : 5

Publication Date : 2021-04-24

Article Type : Research Paper

Abstract :Interferon-free direct-acting antiviral (DAA) therapies in the chronic hepatitis C virus (HCV) infections have low side effects. Sofosbuvir / ribavirin (SOF / RBV) therapy combination is among in the currently approved treatment regimens. Aleopecia areata is a very rarely comlication of this treatment. A case of alopecia areata developed after SOF / RBV combination therapy in a patient with chronic hepatitis C infection is presented.
Keywords : Alopecia areata, hepatitis C virüs, sofosbuvir ribavirin